Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_000548.5(TSC2):āc.2012G>Cā(p.Gly671Ala) variant causes a missense change. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G671C) has been classified as Benign.
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
Loss of catalytic residue at G671 (P = 0.0544);Loss of catalytic residue at G671 (P = 0.0544);Loss of catalytic residue at G671 (P = 0.0544);.;Loss of catalytic residue at G671 (P = 0.0544);Loss of catalytic residue at G671 (P = 0.0544);Loss of catalytic residue at G671 (P = 0.0544);Loss of catalytic residue at G671 (P = 0.0544);.;Loss of catalytic residue at G671 (P = 0.0544);Loss of catalytic residue at G671 (P = 0.0544);Loss of catalytic residue at G671 (P = 0.0544);Loss of catalytic residue at G671 (P = 0.0544);Loss of catalytic residue at G671 (P = 0.0544);.;